3-(2-tert-Butoxycarbonylaminoethyl)-aminocarbonyl-7-metho-
xycoumarin (7a). To a suspension of 7-methoxycoumarin-3-
carboxylic acid 5 (585 mg, 2.66 mmol) in acetonitrile (ACN)
(20 mL) were added NEt3 (0.44 mL, 3.19 mmol), EDC (612 mg,
3.19 mmol) and HOBt (431 mg, 3.19 mmol), followed by a solution
of 6a (638 mg, 3.99 mmol) in ACN (5 mL). The resulting mixture
was stirred at 25 ◦C for 16 h after which solvents were evaporated.
The resulting residue was dissolved in CHCl3 and this solution
was washed successively with saturated Na2CO3 and 0.1 M HCl,
dried over MgSO4 and evaporated under reduced pressure to give
the title compound 7a as an off-white solid (660 mg, 1.82 mmol,
69%).
1H-NMR (400 MHz, CDCl3) d 8.94 (bs, 1H), 8.84 (s, 1H), 7.59
(d, J = 8.4 Hz, 1H), 6.95 (dd, J = 2.4 and 8.8 Hz, 1H), 6.86
(d, J = 2.4 Hz, 1H), 4.98, (bs, 1H), 3.92 (s, 3H), 3.58 (q, J =
5.6 Hz, 2H), 3.38 (q, J = 6.6 Hz, 2H), 1.44 (bs, 9H); 13C-NMR (100
MHz, CDCl3) d 164.7, 162.6, 161.5, 156.5, 155.9, 148.2, 130.8,
114.4, 113.9, 112.1, 100.1, 79.2, 55.9, 40.5, 39.7, 28.2; HRMS (ESI)
Calculated for C18H23N2O6 [M + H]+: 363.1551. Found: 363.1548.
1.20 mmol) in CHCl3 (15 mL) was added TFA (3.69 mL, 48 mmol).
The resulting mixture was stirred at 25 ◦C for 4 h after which
solvents were evaporated under reduced pressure. The resulting
oil was triturated with Et2O to give the corresponding amine as a
TFA salt that was used in the next step without further purification.
To a solution of 4 (489 mg, 1.44 mmol) in ACN were added EDC
(277 mg, 1.44 mmol), HOBt (195 mg, 1.44 mmol), NEt3 (0.20 mL,
1.32 mmol) and a solution of the TFA salt in ACN (5 mL) and
NEt3 (0.20 mL, 1.32 mmol). The resulting mixture was stirred
at 25 ◦C for 18 h after which solvents were evaporated under
reduced pressure. The crude solid was dissolved in CHCl3 and the
resulting solution was washed successively with saturated Na2CO3
and 0.1 M HCl, dried over MgSO4 and evaporated under reduced
pressure to give the title compound 2a as a beige solid (521 mg,
0.892 mmol, 74%).
1H-NMR (400 MHz, CDCl3) d 9.19 (t, J = 5.6 Hz, 1H), 8.98 (s,
1H), 7.90 (d, J = 1.6 Hz, 1H), 7.73 (bs, 1H), 7.62–7.60 (m, 2H),
6.94 (dd, J = 2.8 and 8.8 Hz, 1H), 6.86 (d, J = 2.4 Hz, 1H), 6.51
(d, J = 2.0 Hz, 2H), 3.92 (s, 3H), 3.77–3.74 (m, 2H), 3.70–3.67
(m, 2H), 2,19 (s, 6H); 13C-NMR (75 MHz, DMSO-d6) d 171.5,
170.6, 166.1, 165.7, 163.2, 161.9, 157.5, 149.2, 147.2, 137.0, 133.9,
133,6, 132.8, 128.9, 125.8, 116.1, 114.9, 113.4, 101.5; HRMS (ESI)
Calculated for C30H25N4O9 [M + H]+: 585.1616. Found: 585.1610.
mp 125 ◦C
trans-1-tert-Butoxycarbonylamino-4-(7-methoxycoumarin-3-
carbonyl-amino)cyclohexane (7b). See experimental procedure
detailed for 7a. An off-white solid was isolated (282 mg,
0.677 mmol, 75%).
1H-NMR (400 MHz, CDCl3) d 8.82 (s, 1H), 7.58 (d, J = 8.8 Hz,
1H), 6.93 (dd, J = 2.4 and 8.8 Hz, 1H), 6.86 (d, J = 2.4 Hz, 1H),
4.43 (bs, 1H), 3.91 (bs, 3H), 3.47 (bs, 1H), 2.09–2.07 (m, 4H), 1.62
(s, 1H), 1.45 (bs, 9H), 1.39–1.26 (m, 5H); 13C-NMR (100 MHz,
CDCl3) d 165.6, 162.6, 162.1, 157.4, 156.1, 149.0, 131.7, 115.6,
114.9, 113.2, 101.1, 80.0, 56.8, 49.7, 48.9, 32.9, 32.8, 32.3, 29.2;
HRMS (ESI): Calculated for C22H28N2O6Na [M + Na]+: 439.1840.
Found: 439.1841.
trans-1-tert-Butoxycarbonylamino-4-(7-methoxycoumarin-3-car-
bonylamino)cyclohexane (2b). See experimental procedure
detailed for 2a. A beige solid was isolated (217 mg, 0.340 mmol,
69%).
1H-NMR (400 MHz, CDCl3) d 8.82 (s, 1H), 7.79 (d, J = 1.6 Hz,
1H), 7.64 (d, J = 2.0 Hz, 1H), 7.58 (d, J = 8.8 Hz, 1H), 6.94 (dd,
J = 2.4 and 8.4 Hz, 1H), 6.88 (d, J = 2.4 Hz, 1H), 6.51 (d, J =
1.6 Hz, 2H), 6.06 (bs, 1H), 4.02–3.99 (m, 2H), 3.92 (s, 3H), 2.19–
2.17 (m, 8H), 1.48–1.41 (m, 6H); 13C-NMR (75 MHz, CDCl3) d
170.8, 169.7, 165.9, 165.6, 162.6, 162.1, 157.4, 149.0, 146.9, 137.5,
133.4, 131.8, 128.6, 125.8, 125.6, 115.5, 114.9, 113.2, 101.0, 68.8,
56.9, 49.2, 49.0, 32.3, 26.4, 12.1, 12.0; HRMS (ESI) Calculated for
C34H31N4O9 [M + H]+: 639.2086. Found: 639.2079. mp 194 ◦C
trans-1-tert-Butoxycarbonylamino-2-(7-methoxycoumarin-3-
carbonylamino)cyclohexane (7c). See experimental procedure de-
tailed for 7a. An off-white solid was isolated (612 mg, 1.47 mmol,
97%).
1H-NMR (300 MHz, CDCl3) d 8.82 (s, 1H), 7.58 (d, J = 8.7 Hz,
1H), 6.94 (dd, J = 2.4, 8.7 Hz, 1H), 6.87 (d, J = 2.4 Hz, 1H), 5.01
(d, J = 8.1 Hz, 1H), 3.92 (s, 3H), 3.47 (m, 1H), 2.13 (m, 2H), 1.75
(m, 2H), 1.41 (m, 4H), 1.33 (s, 9H); 13C-NMR (75 MHz, CDCl3) d
165.6, 163.3, 162.2, 157.5, 156.6, 149.0, 131.7, 115.5, 114.8, 113.2,
101.2, 79.8, 56.8, 56.1, 54.0, 33.7, 33.2, 29.1, 25.7, 25.5; HRMS
(ESI) Calculated for C22H29N2O6 [M + H]+: 417.2020. Found:
417.2032. mp 141 ◦C.
trans-1-tert-Butoxycarbonylamino-2-(7-methoxycoumarin-3-car-
bonylamino)cyclohexane (2c). See experimental procedure
detailed for 2a. A beige solid was isolated (122 mg, 0.191 mmol,
47%).
1H-NMR (300 MHz, CDCl3) d 8.96 (s, 1H), 8.88 (d, J = 7.80 Hz,
1H), 7.70 (d, J = 6.9 Hz, 2H), 7.58 (d, J = 8.7 Hz, 1H), 7.45 (m, 1H),
6.85 (dd, J = 2.4 and 8.7 Hz, 1H), 6.78 (d, J = 2.4 Hz, 1H), 6.45 (m,
J = 1.8 Hz 2H), 3.98 (m, 1H), 3.83 (s, 3H), 2.31 (m, 1H), 2.31 (m,
1H), 2.13 (s, 6H), 2.03 (m, 2H), 1.45 (m, 6H); 13C-NMR (75 MHz,
CDCl3) d 170.8, 169.7, 165.7, 165.4, 164.9, 162.5, 157.6, 150.5,
146.8, 137.2, 133.3, 133.2, 132.0, 128.4, 126.2, 124.4, 114.9, 113.4,
100.9, 58.2, 56.8, 53.0, 33.0, 32.7, 25.8, 25.1, 12.1; HRMS (ESI)
Calculated for C34H31N4O9 [M + H]+: 639.2086. Found: 639.2087.
mp 212 ◦C
cis-1-tert-Butoxycarbonylamino-2-(7-methoxycoumarin-3-car-
bonylamino)cyclohexane (7d). See experimental procedure de-
tailed for 7a. An off-white solid was isolated (256 mg, 0.615 mmol,
45%).
1H-NMR (300 MHz, CDCl3) d 9.06 (d, J = 7.6 Hz, 1H), 8.85 (s,
1H); 7.59 (d, J = 8.8 Hz, 1H), 6.94 (dd, J = 2.4 and 8.4 Hz, 1H),
6.88 (d, J = 2.4 Hz, 1H), 5.07 (d, J = 7.6 Hz, 1H), 4.39 (m, 1H), 3.92
(s, 3H), 1.86 (m, 1H), 1.71 (m, 2H), 1.56 (m, 5H), 1.43 (s, 9 H); 13C-
NMR (75 MHz, CDCl3) d 165.66, 162.83, 162.77, 157.47, 156.30,
149.20, 131.76, 115.64, 114.89, 113.24, 101.09, 80.16, 77.51, 77.45,
56.85, 50.02, 31.77, 30.17, 29.72, 29.22; HRMS (ESI) Calculated
for C22H29N2O6 [M + H]+: 417.2020. Found: 417.2020. mp 213 ◦C
cis-1-tert-Butoxycarbonylamino-2-(7-methoxycoumarin-3-car-
bonylamino)cyclohexane (2d). See experimental procedure de-
tailed for 2a. A beige solid was isolated (287 mg, 0.450 mmol,
82%).
1H-NMR (300 MHz, CDCl3) d 9.35 (d, 1H, J = 7.8 Hz), 9.04 (s,
1H), 8.80 (s, 1H), 7.98 (m, 1H), 7.90 (d, J = 1.8 Hz, 1H), 7.63–7.60
3-(2-(3,5-Bi-(3-methylmaleimido)-benzoylamino)ethylaminocar-
bonyl)-7-methoxycoumarin (2a). To a solution of 7a (435 mg,
194 | Org. Biomol. Chem., 2011, 9, 185–197
This journal is
The Royal Society of Chemistry 2011
©